Table 6. Summary of PEPFAR-supported LISs adapted for SARS-CoV-2 testing in 11 countries in their response to the COVID-19 pandemic, April 1, 2020–March 31, 2021*.
| Country | No. PEPFAR-supported laboratories with a SARS-CoV-2 LIS† | LIS category | Month and year the SARS-CoV-2 LIS was implemented in first laboratory |
|---|---|---|---|
| Namibia | 39 | Commercial | Mar 2020 |
| Mozambique | 16 | Commercial | Mar 2020 |
| Eswatini | 2 | Commercial | Apr 2020 |
| Zambia | 24 | Commercial | Apr 2020 |
| Nigeria | 4 | Custom-built | Apr 2020 |
| Uganda | 3 | Custom-built | May 2020 |
| Malawi | 5 | Open-source | Jun 2020 |
| Zimbabwe | 15 | Open-source | Jun 2020 |
| Kenya | 8 | Commercial and custom-built | Jun 2020 |
| Lesotho | 3 | Commercial | Dec 2020 |
| South Sudan | 2 | Open-source | Dec 2020 |
| Total | 121 |
*LIS, laboratory information system; PEPFAR, US President’s Emergency Plan for AIDS Relief. †Number of PEPFAR-supported laboratories with a SARS-CoV-2 LIS includes centralized and decentralized laboratories.